SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MedImmune
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
416 47 0 MEDI
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
241So much for Solly's insight. Merrill got it right.tom pope-12/17/2002
240>>BETHESDA, Md., Dec 17 (Reuters) - A U.S. advisory panel on Tuesday backetuck-12/17/2002
239Briefing at 13.20: MedImmune: Solly finds FDA analysis of FluMist to be equivocatom pope-12/16/2002
238Wyeth Move May Boost MedImmune Flu Vaccine Message 18254052sim1-11/20/2002
237From Briefing.com: >>8:33AM MedImmune pushes back FluMist approval to Martuck-10/24/2002
236>>Published online before print August 9, 2002, 10.1073/pnas.172393399; Ptuck-8/20/2002
235Opinions? Insight? Comments on this ranking????? I'm short MEDI, gulp! <=JBINWC-7/23/2002
234MedImmune Starts Biotech Venture Fund $100 Million Earmaaknahow-7/19/2002
233Got this email alert from Schwab today. Charles Schwab & Co., Inc. Email AlEdscharp-7/11/2002
232Bob, With MEDI going before the FDA in a mere few weeks, what odds do you give fArthur Radley-6/18/2002
231An Open Letter to the Biotech Industry... It's pretty clear that the SThe Fox-6/16/2002
230This article claims that ID Biomed's FluNsure may be superior to FluMist. JEdscharp-6/10/2002
229Thursday May 16, 8:06 am Eastern Time Press Release SOURCE: Epicyte Pharmaceuticscaram(o)uche-5/16/2002
228From my take it is hitting resistance at this moment if it can break it, it willhorsegirl48-4/12/2001
227GAITHERSBURG, Md., March 13 /PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI - newsnigel bates-3/13/2001
226Are there any chartists out there? Can you tell us ANYthing in the chart that sToby Zidle-2/9/2001
225not exactly a near-term threat, if a thret at all....... Tuesday September 5, 1scaram(o)uche-9/5/2000
224 MedImmune to Promote David Mott to Chief Executive Officer; Wayne Hockmeyer to bob zagorin-6/6/2000
223 Hi bob - about a month ago, Maykin Ho [or MER?] the top rated biotech analyst, Bosco-6/6/2000
222 Salomon Smith Barney's well-respected bio analyst Meirav Chovav strongly rebob zagorin-6/5/2000
221 Hi Manny - when I got into biotech in Mid March [yikes, I know, I bought at theBosco-6/5/2000
220 I got into MEDI for split play. But doing my DD, MEDI looks like long term holdManny-6/5/2000
219 I don't follow it closely. It has been a great long term hold for me, and Mary Kay-6/5/2000
218 Hi Manny - I am still here. While this may be anecdotal, of the 3 biotechs in mBosco-6/5/2000
217 Anyone still following MEDI? It held up quite well today. There wasn't mucManny-6/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News